Fig. 3
The effect of +49 and CT60 genotype and haplotype on GVHD in AL and ALL patients. a aGVHD III-IV in AL patients according to +49 genotype(GG/GA+AA) and haplotype with or without ACGG/ACGG (PÂ =Â 0.031). b Extensive cGVHD in ALL patients according to CT60 genotype (GG/GA+AA) and haplotype without or with ACAA (PÂ =Â 0.034)